IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial February 23, 2026 Read More »
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer’s Research February 26, 2026 Read More »
IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets February 24, 2026 Read More »